Jing Song Wang
Chief Executive Officer at HBM HOLDINGS LIMITED
Jing Song Wang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FRONTAGE HOLDINGS CORPORATION | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| HBM HOLDINGS LIMITED | Chief Executive Officer | 19/07/2016 | - |
| Chairman | 19/07/2016 | - | |
| Founder | 19/07/2016 | - | |
| XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Director/Board Member | 16/09/2021 | - |
| Independent Dir/Board Member | 16/09/2021 | - | |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Chief Executive Officer | - | - |
| Chairman | - | - | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Director/Board Member | 31/07/2016 | - |
| Independent Dir/Board Member | 31/07/2016 | - | |
| Hbm Suzhou Co. Ltd. | Chief Executive Officer | - | - |
| Hbm Guangzhou | Chief Executive Officer | - | - |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Director/Board Member | 31/05/2023 | - |
| Independent Dir/Board Member | 31/05/2023 | - |
Career history of Jing Song Wang
Former positions of Jing Song Wang
| Companies | Position | Start | End |
|---|---|---|---|
| Sanofi (China) Investment Co. Ltd. | Corporate Officer/Principal | 31/10/2011 | 30/11/2015 |
Training of Jing Song Wang
| China Pharmaceutical University | Doctorate Degree |
| Jilin University | Graduate Degree |
| Xuzhou Medical University | Graduate Degree |
Statistics
International
| China | 9 |
| Cayman Islands | 4 |
| United States | 2 |
Operational
| Chief Executive Officer | 4 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 4 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| FRONTAGE HOLDINGS CORPORATION | Health Technology |
| HBM HOLDINGS LIMITED | Health Technology |
| XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Commercial Services |
| Private companies | 6 |
|---|---|
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
| Hbm Suzhou Co. Ltd. | |
| Hbm Guangzhou | |
| Sanofi (China) Investment Co. Ltd. | |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Jing Song Wang
- Experience
